FCPA Investigation: Former Chief Technology Officer of Publicly Traded Health Care Company

Represented former Chief Technology Officer of a publicly traded health care company in ongoing federal Foreign Corrupt Practices Act (FCPA) investigation regarding business of China subsidiary.